News Release

Aging (Aging-US) supports landmark senescence and aging research events in Rome

For the first time, the leading fundamental science meeting on cellular senescence will be directly connected with a global summit dedicated to the clinical and commercial development of senotherapeutics

Business Announcement

Impact Journals LLC

Aging (Aging-US) Supports Landmark Senescence and Aging Research Events in Rome

image: 

10th Annual ICSA Conference & 2nd Phaedon SenoTherapeutics Summit from September 16th-19th, 2025
Rome, Italy.

view more 

Credit: Courtesy of https://icsa2025rome.com/

For the first time, the leading fundamental science meeting on cellular senescence will be directly connected with a global summit dedicated to the clinical and commercial development of senotherapeutics.

BUFFALO, NY — August 11, 2025 — Aging (Aging-US) is proud to support a milestone event for the global senescence and aging research community.

This coming September 16-19, 2025, Rome, Italy will host two back-to-back events that will define the next chapter of senescence science and translation:

  • 10th Annual International Cell Senescence Association (ICSA) Conference
  • Senotherapeutics Summit – organized with the Phaedon Institute

This combined program could not come at a more important time. The field is entering a transformative phase:

  • Multiple clinical trials on senolytics and senomorphics are now reporting results, offering the first real-world evidence of their therapeutic potential.
  • Exciting new discoveries in senescence mechanisms, biomarkers, and tissue-specific roles are reshaping our understanding of when and how to target these cells.

For the first time, the leading fundamental science meeting on cellular senescence will be directly connected with a global summit dedicated to the clinical and commercial development of senotherapeutics. This unique integration will allow participants to seamlessly move from bench to bedside discussions, exploring both the latest research and its translation into therapies that could transform how we approach aging and age-related diseases.

Highlights include:

  • Keynotes from pioneers driving both discovery science and translational innovation.
  • Sessions on mechanisms, biomarkers, and emerging targets.
  • Industry and regulatory panels on clinical trial design, safety, and approval pathways.
  • Case studies from ongoing and completed human trials.
  • Networking with leaders from academia, biotech and pharma.

Celebrate a decade of ICSA and help chart the path for the next generation of senescence science and therapeutics.

Registration is still open: https://icsa2025rome.com/

______

To learn more about the journal, please visit our website at www.Aging-US.com​​ and connect with us on social media at:

Click here to subscribe to Aging publication updates.

For media inquiries, please contact media@impactjournals.com.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.